Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.490
-0.190 (-5.16%)
Jun 3, 2026, 1:34 PM EDT - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $569.06 million as of June 3, 2026. Its market cap has increased by 452.44% in one year.
Market Cap
569.06M
Enterprise Value
509.86M
1-Year Change
452.44%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $569.06M, an increase of 141.61%. That is a compound annual growth rate of 14.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 600.04M | 184.62% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 654.55M |
| SpyGlass Pharma | 643.80M |
| Prime Medicine | 641.19M |
| Aclaris Therapeutics | 635.47M |
| Immix Biopharma | 628.12M |
| Ginkgo Bioworks Holdings | 612.09M |
| Candel Therapeutics | 608.14M |
| Altimmune | 593.15M |